Trial Profile

Benefits and Safety of Early Tirofiban in the Treatment of Patients with Acute Coronary Syndrome : a Prospective , Multicenter and Randomized controlled trial.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tirofiban (Primary)
Indications Acute coronary syndromes; Myocardial infarction
Focus Therapeutic Use
Acronyms BESTOWAL

Most Recent Events

22 Nov 2013 Planned number of patients changed from 3000 to 852 as reported by Chinese Clinical Trial Register.
31 May 2013 Status changed from recruiting to completed as reported by Chinese Clinical Trial Register.
21 May 2012 Planned end date changed from 1 May 2012 to 31 May 2013 as reported by Chinese Clinical Trial Register.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com